P.0226 Indirect comparison estimating the benefit of esketamine compared to distinct real-world treatment strategies for treatment resistant depression in general psychiatry

Autor: Rive, B., Oliveira-Maia, A.J., Falissard, B., Haughey, S. Mulhern, Barbreau, S., Godinov, Y., Morrens, J.
Zdroj: In European Neuropsychopharmacology December 2021 53 Supplement 1:S163-S165
Databáze: ScienceDirect